Sana Alajmovic Interviewed by Redeye on Enzymatica’s Next Growth Phase

Enzymatica’s CEO Sana Alajmovic is featured in a new interview with Redeye, where she shares her views on the company’s future and what she aims to contribute in her new role. 

In the interview, Sana highlights Enzymatica’s strong scientific foundation, the unique platform technology behind ColdZyme, and the opportunities to accelerate the company’s international expansion. She also outlines a forward-looking focus on commercial growth, strategic partnerships, and further strengthening the brand’s position in new markets.

With her background in innovation, entrepreneurship, and global business development, Sana aims to bring pace, strategic clarity, and strong commercial execution as Enzymatica enters its next phase.

Watch the full interview with Sana Alajmovic on Redeye here: Enzymatica's Next Growth Phase